POSITION: NEWS >> Content

Rational Drug Design and Lead Optimization

Wed, Aug 19 2015 04:29 PM  Click:[]

报告人:Hongbing Huang, Ph.D.              

INNOVATIVE DRUG HUNTER

An active thinker, problem-solver, team player and quick learner. Motivated medicinal chemist with extensive experience in leading drug discovery projects. Hands-on experience in design, discovery and development of small molecules against enzyme targets and ion channels. Expert in combinatorial and parallel library synthesis.

RESEARCH EXPERIENCE

Senior Scientist

2006-present

Amgen Inc., Cambridge, Massachusetts

· Project technical leadership: Design and execution of chemistry strategy, structure-based drug design, analyze structure-activity/property relationship, evaluate and optimize synthetic route.

· Intellectual property management: Analyze competitive landscape, assess patent portfolio, develop patenting strategy and generate advantaged IP asset.

· Design and synthesize novel inhibitors for enzymes and ion channels. Apply organic chemistry and medicinal chemistry principles to library synthesis.

· Discovered a novel chemical scaffold for BACE inhibition which led to the identification of a clinical drug candidate. The contribution was recognized by an Amgen Bravo award (3 star).

Postdoctoral Fellow

2004-2006

with Professor Eric N. Jacobsen, Harvard University, Cambridge, Massachusetts

· Applied catalysis and process chemistry fundamentals to develop a catalytic process for enantioselective synthesis of chiral nitroalkanes.

Research Assistant

1999-2004

with Professor James S. Panek, Boston University, Boston, Massachusetts

· Developed a practical process for stereoselective synthesis of functionalized dihydropyrans.

· Developed a new method for asymmetric synthesis of chiral tetrahydropyridines.

· Completed total synthesis of marine macrolide callipeltoside A. Developed a Cr (VI)-catalyzed oxidative C-C bond cleavage reaction. Optimized a Rh (I)-catalyzed C-H insertion reaction.

· Completed total synthesis of quinolizidine alkaloid (-)-217A and established the absolute configuration of natural 217A.

Research Assistant

1993-1996

with Professor Jiyu Yang, West China University of Medical Sciences, Chengdu, P.R.China

· Prepared lipid-conjugated modified bovine SODs and assessed their enzymatic activity and stability.

时间:2015819日(星期)上午1000

地点:化学楼102会议室

欢迎广大师生参加!


Pre:New Vistas in the Asymmetric Construction of C-N and C-C Bonds

Close

Contact
  • TEL:0871-65031119
  • ADD:2 North Cuihu Rd. 650091 Kunming

Yunnan University © 2007-2017 All Rights Services